Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Activating mutation in MET oncogene in familial colorectal cancer.

Neklason DW, Done MW, Sargent NR, Schwartz AG, Anton-Culver H, Griffin CA, Ahnen DJ, Schildkraut JM, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Burt RW.

BMC Cancer. 2011 Oct 4;11:424. doi: 10.1186/1471-2407-11-424.

2.

Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.

Lindor NM, Dechet CB, Greene MH, Jenkins RB, Zincke MT, Weaver AL, Wilson M, Zincke H, Liu W.

Genet Test. 2001 Summer;5(2):101-6. Review.

PMID:
11551094
4.
5.

Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.

Johnson V, Lipton LR, Cummings C, Eftekhar Sadat AT, Izatt L, Hodgson SV, Talbot IC, Thomas HJ, Silver AJ, Tomlinson IP.

J Med Genet. 2005 Oct;42(10):756-62. Epub 2005 Mar 23.

6.

A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.

Boardman LA, Schmidt S, Lindor NM, Burgart LJ, Cunningham JM, Price-Troska T, Snow K, Ahlquist DA, Thibodeau SN.

Genes Chromosomes Cancer. 2001 Feb;30(2):181-6.

PMID:
11135435
7.
8.

Familial risks for colorectal cancer show evidence on recessive inheritance.

Hemminki K, Chen B.

Int J Cancer. 2005 Jul 10;115(5):835-8.

9.

Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study.

Wish TA, Hyde AJ, Parfrey PS, Green JS, Younghusband HB, Simms MI, Fontaine DG, Dicks EL, Stuckless SN, Gallinger S, McLaughlin JR, Woods MO, Green RC.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1831-9. doi: 10.1158/1055-9965.EPI-10-0055. Epub 2010 Jun 22.

10.

TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk.

Skoglund Lundin J, Vandrovcova J, Song B, Zhou X, Zelada-Hedman M, Werelius B, Houlston RS, Lindblom A.

Br J Cancer. 2009 May 19;100(10):1674-9. doi: 10.1038/sj.bjc.6605054. Epub 2009 Apr 28.

11.
12.

Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.

Bellido F, Sowada N, Mur P, Lázaro C, Pons T, Valdés-Mas R, Pineda M, Aiza G, Iglesias S, Soto JL, Urioste M, Caldés T, Balbín M, Blay P, Rueda D, Durán M, Valencia A, Moreno V, Brunet J, Blanco I, Navarro M, Calin GA, Borck G, Puente XS, Capellá G, Valle L.

Gastroenterology. 2018 Jan;154(1):181-194.e20. doi: 10.1053/j.gastro.2017.09.005. Epub 2017 Sep 12.

PMID:
28912018
13.

Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer.

Möckelmann N, von Schönfels W, Buch S, von Kampen O, Sipos B, Egberts JH, Rosenstiel P, Franke A, Brosch M, Hinz S, Röder C, Kalthoff H, Fölsch UR, Krawczak M, Schreiber S, Bröring CD, Tepel J, Schafmayer C, Hampe J.

BMC Gastroenterol. 2009 Oct 20;9:79. doi: 10.1186/1471-230X-9-79.

14.

Genetic variations of the A13/A14 repeat located within the EGFR 3' untranslated region have no oncogenic effect in patients with colorectal cancer.

Sarafan-Vasseur N, Sefrioui D, Tougeron D, Lamy A, Blanchard F, Le Pessot F, Di Fiore F, Michel P, Bézieau S, Latouche JB, Frebourg T, Sesboüé R.

BMC Cancer. 2013 Apr 8;13:183. doi: 10.1186/1471-2407-13-183.

15.

A novel germ line juxtamembrane Met mutation in human gastric cancer.

Lee JH, Han SU, Cho H, Jennings B, Gerrard B, Dean M, Schmidt L, Zbar B, Vande Woude GF.

Oncogene. 2000 Oct 12;19(43):4947-53.

16.

A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.

Baudi F, Fersini G, Lavecchia A, Terracciano R, Leone F, Quaresima B, Faniello MC, De Paola L, Doldo P, Cuda G, Costanzo F, Venuta S.

Cancer Lett. 2005 Jun 8;223(2):285-91. Epub 2004 Nov 25.

PMID:
15896463
17.

Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.

Balaguer F, Castellví-Bel S, Castells A, Andreu M, Muñoz J, Gisbert JP, Llor X, Jover R, de Cid R, Gonzalo V, Bessa X, Xicola RM, Pons E, Alenda C, Payá A, Piqué JM; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):379-87.

PMID:
17368238
18.

Clinical impact of c-MET expression and mutational status in patients with colorectal cancer lung metastases.

Schweiger T, Starkl V, Glueck O, Glogner C, Traxler D, Jedamzik J, Liebmann-Reindl S, Birner P, Streubel B, Klepetko W, Hoetzenecker K.

Eur J Cardiothorac Surg. 2016 Apr;49(4):1103-11; discussion 1111. doi: 10.1093/ejcts/ezv323. Epub 2015 Oct 24.

PMID:
26503729
19.

Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.

Samadder NJ, Curtin K, Tuohy TM, Rowe KG, Mineau GP, Smith KR, Pimentel R, Wong J, Boucher K, Burt RW.

Gastroenterology. 2014 Oct;147(4):814-821.e5; quiz e15-6. doi: 10.1053/j.gastro.2014.07.006. Epub 2014 Jul 17.

PMID:
25042087
20.

Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome.

Wong P, Verselis SJ, Garber JE, Schneider K, DiGianni L, Stockwell DH, Li FP, Syngal S.

Gastroenterology. 2006 Jan;130(1):73-9.

PMID:
16401470

Supplemental Content

Support Center